The Brazilian oil company announced this Monday (20) its goal of neutralizing greenhouse gas emissions in operations under its control, following the deadlines of the Paris Agreement.
Author: Agência Brasil
The National Monetary Council and the Central Bank of Brazil changed regulation to streamline international payments and remittances.
According to the Brazilian Ministry of Health data, 64 million people took the second shot or single shot of the vaccines against the coronavirus.
Regulation by the Brazilian National Health Surveillance Agency facilitating the international purchase of essential drugs for the fight against COVID-19 will continue to apply.
Think tank Getúlio Vargas Foundation’s indicator grew in the third quarter, representing a more favorable economic climate in Latin American countries like Paraguay and Brazil.
Solid bulk cargo accounted for 58% of the weight handled by Brazilian ports in the first half of the year, especially ore and oil. The Port of Vitória saw the highest hike.
According to IBGE estimates, the Brazilian harvest of grains, cereals, and legumes should total 256.1 million tonnes this year. The soybean harvest has already been completed with excellent results.
Twenty-five percent of the fuel the country uses now comes from renewable sources. The goal is to reach 2030 with a 30% share.
Researchers at Unifesp and UFRJ managed to identify the presence of the virus in the retinae of patients, which is expected to contribute to the international understanding of the disease and its sequelae.
Indicator points out that investments in May stepped up by 1.6% month on month and 0.5% year on year. Components include purchases of production machinery.
The document attesting complete immunization against COVID-19 can be issued in Portuguese, English and Spanish in Brazil. These versions are helpful for those who are traveling abroad.
Due to foreign trade performance, the International Monetary Fund projects an increase of 5.3% for the country’s GDP this year, 1.6% above the April estimate. For next year, however, the outlook has worsened.
Decree published on Monday (26) has extended the list of medical, hospital and hygiene products that cannot be exported as they are essential to fighting COVID in the country.
The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
